HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants. Felton JL, Cuthbertson D, Warnock M, Lohano K, et al. Diabetologia 2021 Oct 12. pii: 10.1007/s00125-021-05573.

Read + Share

Amedeo Smart

Independent Medical Education

Felton JL, Cuthbertson D, Warnock M, Lohano K, et al. HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants. Diabetologia 2021 Oct 12. pii: 10.1007/s00125-021-05573.
PMID: 34642772